Gene therapy of rat C6 glioma using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene: Long-term follow-up by magnetic resonance imaging

Gene Therapy

Volumn 3, Issue 4, 1996, Pages 315-322

  Maron, A ^a   Gustin, T ^b   Le Roux, A ^c   Mottet, I ^b   Dedieu, J F ^c   Brion, J P ^d   Demeure, R ^b   Perricaudet, M ^c   Octave, J N ^a,b  

^a Laboratoire de Neurochimie   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Adenovirus vector; Brain tumor; Gene therapy; Herpes simplex thymidine kinase; Magnetic resonance imaging

Indexed keywords

GANCICLOVIR; THYMIDINE KINASE;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN TUMOR; CAUDATE NUCLEUS; CONTROLLED STUDY; EXPRESSION VECTOR; GENE THERAPY; GLIOMA; GLIOMA CELL; HEMISPHERE; HERPES SIMPLEX VIRUS; IMAGING; INTRACARDIAC DRUG ADMINISTRATION; MALE; MULTIMODALITY CANCER THERAPY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; SURVIVAL TIME; TUMOR RECURRENCE; TUMOR REGRESSION; TUMOR VOLUME;

ADENOVIRIDAE; ANIMALS; BRAIN NEOPLASMS; GANCICLOVIR; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, VIRAL; GENETIC VECTORS; GLIOMA; MAGNETIC RESONANCE IMAGING; MALE; RATS; RATS, WISTAR; SIMPLEXVIRUS; THYMIDINE KINASE; TIME FACTORS;

ADENOVIRIDAE; ANIMALIA; HERPES; SIMPLEXVIRUS;

EID: 0029991063     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Schoenberg BS. The epidemiology of nervous system tumors. In: MD Walker (ed). Oncology of the Nervous System. Martinus Nijhoff: Boston, 1983, pp 1-30.
2. Daumas-Duport C, Scheithauer B, O'Fallon J, Kelly P. Grading of astrocytomas: a simple and reproducible method. Cancer 1988; 62: 2152-2165.
3. Mahaley MS et al. National survey of patterns of care for brain-tumor patients. J Neurosurg 1989; 71: 826-836.
4. Dalgleish AG. The role of IL-2 in gene therapy. Gene Therapy 1994; 1: 83-87.
5. Heslop HE. Cytokine gene transfer in the therapy of malignancy. Baillière's Clin Haematol 1994; 7: 135-151.
6. Tepper TI, Mulé JJ. Experimental and clinical studies of cytokine gene-modified tumor cells. Hum Gene Ther 1994; 5: 153-164.
7. Wei MX et al. Genetic treatment of intracerebral rodent brain tumors with an interleukin-4 retrovirus vector. Soc Neurosci 1993; 19: 1071 (abstr.).
8. Ram Z et al. In vivo transfer of the human interleukin-2 gene: negative tumoricidal results in experimental brain tumors. J Neurosurg 1994; 80: 535-540.
9. Moolten FL. Tumor chemosensitivity conferred by inserted Herpes simplex thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res 1986; 46: 5276-5281.
10. Moolten FL, Wells JM. Curability of tumors bearing Herpes thymidine kinase genes transferred by retroviral vectors. J Natl Cancer Inst 1990; 82: 297-300.
11. Moolten FL, Wells JM, Heyman RA, Evans RM. Lymphoma regression induced by ganciclovir in mice bearing a Herpes thymidine kinase transgene. Hum Gene Ther 1990; 1: 125-134.
12. Ezzedine ZD et al. Selective killing of glioma cells in culture and in vivo by retrovirus transfer of the Herpes simplex virus thymidine kinase gene. New Biol 1991; 3: 608-614.
13. Takamiya Y. Gene therapy of malignant brain tumors: a rat glioma line bearing the Herpes simplex virus type 1-thymidine kinase gene and wild-type retrovirus kills other tumor cells. J Neurosci Res 1992; 33: 493-503.
14. Takamiya Y et al. An experimental model of retrovirus gene therapy for malignant brain tumors. J Neurosurg 1993; 79: 104-110.
15. Barba D, Hardin J, Ray J, Gage FH. Thymidine kinase-mediated killing of rat brain tumors. J Neurosurg 1993; 79: 729-735.
16. Caruso M et al. Regression of established macroscopic liver metastases after in situ transduction of a suicide gene. Proc Natl Acad Sci USA 1993; 90: 7024-7028.
17. Culver KW et al. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 1992; 256. 1550-1552.
18. Ram Z et al. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res 1993; 53: 83-88.
19. Barba D, Hardin J, Sadelain M, Gage FH. Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors. Proc Natl Acad Sci USA 1994; 91: 4348-4352.
20. Chen SH et al. Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc Natl Acad Sci USA 1994; 91: 3054-3057
21. Perez-Cruet MJ et al. Adenovirus-mediated gene therapy of experimental gliomas J Neurosci Res 1994; 39. 506-511.
22. Izquierdo M et al. Long-term rat survival after malignant brain tumor regression by retroviral gene therapy. Gene Therapy 1995; 2: 66-69.
23. Oldfield EH et al Gene therapy for the treatment of brain tumors using intratumoral transduction with the thymidine kinase gene and intravenous ganciclovir. Hum Gene Ther 1993; 4: 39-69.
24. Culver KW et al. Gene therapy for the treatment of malignant brain tumors with in vivo tumor transduction with the Herpes simplex thymidine kinase gene/ganciclovir system. Hum Gene Ther 1994; 5: 343-379.
25. Stratford-Perricaudet LD, Makeh I, Perricaudet M, Briand P. Widespread long-term gene transfer to mouse skeletal muscles and heart. J Clin Invest 1992; 90: 626-630.
26. Le Gal La Salle G et al. An adenovirus vector for gene transfer into neurons and glia in the brain. Science 1993; 259: 988-990.
27. Boviatsis EJ et al. Gene transfer into experimental brain tumors mediated by adenovirus, Herpes simplex virus, and retrovirus vectors. Hum Gene Ther 1994; 5: 183-191.
28. Wu JK et al. Bystander effect in the treatment of experimental brain tumors. Neurosurgery 1994; 35: 1094-1103.
29. Bi WL, Parysek LM, Warnick R, Stambrook PJ. In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSVtk retroviral gene therapy. Hum Gene Ther 1993; 4: 725-731.
30. Freeman SM et al. The 'bystander effect': tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res 1993; 53: 5274-5283.
31. Ram Z et al. The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculafure and growth of 9L gliomas in rats. J Neurosurg 1994; 81: 256-260.
32. Badie B, Hunt K, Economou JS, Black KL. Stereotactic delivery of a recombinant adenovirus into a C6 glioma cell line in a rat brain tumor model. Neurosurgery 1994; 35: 910-916.
33. Viola JJ et al. Adenovirally mediated gene transfer into experimental solid brain tumors and leptomeningeal cancer cells. J Neurosurg 1995; 82: 70-76.
34. Yang Y et al. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA 1994; 91: 4407-4411.
35. Yang Y, Li Q, Ertl HCJ, Wilson JM. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J Virol 1995; 69: 2004-2015.
36. Yang Y et al. Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nat Genet 1994; 7: 362-369.
37. Haddada H et al. Adenoviral interleukin-2 gene transfer into P 815 tumor cells abrogates tumorigenicity and induces anti-tumoral immunity in mice. Hum Gene Ther 1993; 4: 703-711.
38. Cordier L et al. Complete recovery of mice from a pre-established tumor by direct intratumoral delivery of an adenovirus vector harboring the murine IL-2 gene. Gene Therapy 1995; 2: 16-21.
39. Liu TJ et al. Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus. Cancer Res 1994; 54: 3662-3667.
40. Clayman GL et al. In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma. Cancer Res 1995; 55: 1-6.
41. Graham FL, Van Der Eb EJ. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 1973; 52: 456-467.
42. Benda P et al. Differentiated rat glial cell strain in tissue culture. Science 1968; 161: 370.
43. Graham FL, Smiley J, Russell WC, Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 1977; 36: 59-72.
44. Hansen MB, Nielson SE, Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Meth 1989; 119: 203-210.
45. Benabid AL, Remy C, Chauvin C. Experimental models of rat brain tumors by stereotactic injection of C6 glioma and HTC hepatoma cell lines. In: MD Walker (ed). Biology of Brain Tumor. Martinus Nijhoff: Boston, 1986, pp 221-226.
46. Kobayashi N, Allen N, Clendenon NR, Ko LW. An improved rat brain-tumor model. J Neurosurg 1980; 53: 808-815.